Back

The negative symptoms of schizophrenia: lessons from a precision nomothetic psychiatry approach

Maes, M.

2022-05-27 psychiatry and clinical psychology
10.1101/2022.05.26.22275663 medRxiv
Show abstract

The present study aims to explain how to use the precision nomothetic approach to analyze the interconnections between the negative symptoms, cognitive dysfunctions and biomarkers of schizophrenia. We review our data obtained in different study groups of patients with (deficit) schizophrenia and show, using examples extracted from these studies, how Partial Least Squares (PLS) path analysis should be used to examine these complex associations. PLS path analysis combines factor and multiple regression analysis in mediated models. We show that a single latent trait can be extracted from negative symptom domains and psychosis, hostility, excitation, mannerism, formal thought disorders and psychomotor retardation (PHEMFP). Both the negative and PHEMFP concepts miss discriminant validity whilst a common latent construct may be extracted from the 6 negative and 6 PHEMFP subdomains, dubbed overall severity of schizophrenia (OSOS). A common latent factor may be extracted from neurocognitive test scores including executive functions, and semantic and episodic memory dubbed the general cognitive decline (G-CoDe) index. PLS analysis shows that the effects of neuroimmunotoxic pathways on OSOS are partly mediated by the G-CoDe and indicate that those pathways have also direct effects on OSOS. We explain that the intercorrelations between those features should be assessed in an unrestricted study group combining patients and controls. Moreover, further bifactorial factor analysis with the restricted schizophrenia group may disclose illness-specific covariations among the features. Machine learning discovered a new schizophrenia phenotype characterized by increased severity of AOPs, G-CoDe, and OSOS, dubbed "major neurocognitive psychosis".

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Schizophrenia Research
29 papers in training set
Top 0.1%
28.3%
2
Schizophrenia Bulletin
29 papers in training set
Top 0.1%
10.3%
3
Schizophrenia
19 papers in training set
Top 0.1%
10.3%
4
Translational Psychiatry
219 papers in training set
Top 0.8%
7.0%
50% of probability mass above
5
NeuroImage: Clinical
132 papers in training set
Top 1.0%
4.4%
6
Progress in Neuro-Psychopharmacology and Biological Psychiatry
36 papers in training set
Top 0.1%
3.7%
7
Frontiers in Psychiatry
83 papers in training set
Top 1%
3.7%
8
Psychiatry Research
35 papers in training set
Top 0.5%
3.1%
9
Biological Psychiatry
119 papers in training set
Top 1%
2.7%
10
Scientific Reports
3102 papers in training set
Top 47%
2.4%
11
PLOS ONE
4510 papers in training set
Top 52%
1.7%
12
Molecular Psychiatry
242 papers in training set
Top 2%
1.7%
13
Computational Psychiatry
12 papers in training set
Top 0.1%
1.4%
14
European Journal of Neuroscience
168 papers in training set
Top 0.9%
1.0%
15
Brain Topography
23 papers in training set
Top 0.3%
0.8%
16
Cerebral Cortex
357 papers in training set
Top 2%
0.8%
17
Brain and Behavior
37 papers in training set
Top 1%
0.8%
18
Biology of Sex Differences
29 papers in training set
Top 0.7%
0.8%
19
International Journal of Environmental Research and Public Health
124 papers in training set
Top 7%
0.8%
20
Acta Psychiatrica Scandinavica
10 papers in training set
Top 0.4%
0.7%
21
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 2%
0.7%
22
Human Brain Mapping
295 papers in training set
Top 5%
0.5%
23
Acta Neuropsychiatrica
12 papers in training set
Top 1%
0.5%
24
Frontiers in Pharmacology
100 papers in training set
Top 6%
0.5%
25
BMC Psychiatry
22 papers in training set
Top 0.9%
0.5%